152 related articles for article (PubMed ID: 35817472)
1. Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus.
Abe N; Tarumi M; Fujieda Y; Takahashi N; Karino K; Uchida M; Kono M; Tanaka Y; Hasebe R; Kato M; Amengual O; Arinuma Y; Oku K; Sato W; Tha KK; Yamasaki M; Watanabe M; Atsumi T; Murakami M
Ann Rheum Dis; 2022 Nov; 81(11):1564-1575. PubMed ID: 35817472
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of NF-κB Kinase Subunit ε Contributes to Neuropsychiatric Manifestations in Lupus-Prone Mice Through Microglial Activation.
Karino K; Kono M; Takeyama S; Kudo Y; Kanda M; Abe N; Aso K; Fujieda Y; Kato M; Oku K; Amengual O; Atsumi T
Arthritis Rheumatol; 2023 Mar; 75(3):411-423. PubMed ID: 36098515
[TBL] [Abstract][Full Text] [Related]
3. Microglia orchestrate synaptic and neuronal stripping: Implication in neuropsychiatric lupus.
Zhou Y; Chen L; Zheng X; Fang Q; Qian Y; Xu T; Liang J; Zhang H; Han X; Sun L
J Cell Mol Med; 2024 Apr; 28(7):e18190. PubMed ID: 38494844
[TBL] [Abstract][Full Text] [Related]
4. Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus.
Reynolds J; Huang M; Li Y; Meineck M; Moeckel T; Weinmann-Menke J; Mohan C; Schwarting A; Putterman C
J Neuroinflammation; 2024 Apr; 21(1):89. PubMed ID: 38600510
[TBL] [Abstract][Full Text] [Related]
5. Treatment with lysophosphatidic acid prevents microglial activation and depression-like behaviours in a murine model of neuropsychiatric systemic lupus erythematosus.
Nagata W; Koizumi A; Nakagawa K; Takahashi S; Gotoh M; Satoh Y; Ishizuka T
Clin Exp Immunol; 2023 Apr; 212(2):81-92. PubMed ID: 36718978
[TBL] [Abstract][Full Text] [Related]
6. Pyruvate kinase isoform M2 impairs cognition in systemic lupus erythematosus by promoting microglial synaptic pruning via the β-catenin signaling pathway.
Lu L; Wang H; Liu X; Tan L; Qiao X; Ni J; Sun Y; Liang J; Hou Y; Dou H
J Neuroinflammation; 2021 Oct; 18(1):229. PubMed ID: 34645459
[TBL] [Abstract][Full Text] [Related]
7. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
8. Ectopic CD4
Wang K; Hou X; Lu H; Han N; Xie M; Xi A; Xu Z
J Autoimmun; 2024 May; 145():103199. PubMed ID: 38452512
[TBL] [Abstract][Full Text] [Related]
9. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
11. The correlation between proteoglycan 2 and neuropsychiatric systemic lupus erythematosus.
Qiao X; Lu L; Zhou K; Tan L; Liu X; Ni J; Hou Y; Liang J; Dou H
Clin Immunol; 2022 Jun; 239():109042. PubMed ID: 35568106
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling.
Mike EV; Makinde HM; Der E; Stock A; Gulinello M; Gadhvi GT; Winter DR; Cuda CM; Putterman C
Front Immunol; 2018; 9():2189. PubMed ID: 30319641
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychiatric systemic lupus erythematosus persists despite attenuation of systemic disease in MRL/lpr mice.
Stock AD; Wen J; Doerner J; Herlitz LC; Gulinello M; Putterman C
J Neuroinflammation; 2015 Nov; 12():205. PubMed ID: 26546449
[TBL] [Abstract][Full Text] [Related]
14. Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.
Wen J; Xia Y; Stock A; Michaelson JS; Burkly LC; Gulinello M; Putterman C
J Autoimmun; 2013 Jun; 43():44-54. PubMed ID: 23578591
[TBL] [Abstract][Full Text] [Related]
15. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus.
Shi D; Tian T; Yao S; Cao K; Zhu X; Zhang M; Wen S; Li L; Shi M; Zhou H
Brain Behav Immun; 2018 May; 70():293-304. PubMed ID: 29548997
[TBL] [Abstract][Full Text] [Related]
16. Treatment with lysophosphatidic acid improves glomerulonephritis through the suppression of macrophage activation in a murine model of systemic lupus erythematosus.
Nagata W; Takayama E; Nakagawa K; Koizumi A; Ohsawa Y; Goto H; Yamashiro A; Ishinoda Y; Tanoue K; Kumagai H; Oshima N; Ishizuka T
Clin Exp Rheumatol; 2024 Mar; 42(3):658-665. PubMed ID: 38436267
[TBL] [Abstract][Full Text] [Related]
17. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
18. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
19. Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
Zhou J; Lu F; Li S; Xie M; Lu H; Xie Z; Wu D; Wang S; Wen C; Xu ZH
Inflammopharmacology; 2020 Apr; 28(2):425-435. PubMed ID: 31786803
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
Yang J; Li Q; Yang X; Li M
Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
